296 related articles for article (PubMed ID: 29284320)
1. Clinical and virologic effects of four neuraminidase inhibitors in influenza A virus-infected children (aged 4-12 years): an open-label, randomized study in Japan.
Hirotsu N; Saisho Y; Hasegawa T; Shishido T
Expert Rev Anti Infect Ther; 2018 Feb; 16(2):173-182. PubMed ID: 29284320
[TBL] [Abstract][Full Text] [Related]
2. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
[TBL] [Abstract][Full Text] [Related]
3. Clinical effects of oseltamivir, zanamivir, laninamivir and peramivir on seasonal influenza infection in outpatients in Japan during the winter of 2012-2013.
Takemoto Y; Asai T; Ikezoe I; Yano T; Ichikawa M; Miyagawa S; Matsumoto J
Chemotherapy; 2013; 59(5):373-8. PubMed ID: 24821568
[TBL] [Abstract][Full Text] [Related]
4. Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014-2015 to 2016-2017 influenza seasons in Japan.
Ishiguro N; Koseki N; Kaiho M; Ariga T; Kikuta H; Oba K; Togashi T; Morita K; Inagawa A; Okamura A; Yamazaki S; Shida S; Konno M; Kawamura N; Ishizaka A; Takada K; Tsubakihara K; Nagano N; Shibata M; Furuyama H; Matsuzono Y; Koike A; Murashita M; Hatae Y; Arioka H; Yamanaka T; Watanabe T; Tabata Y; Kumita Y; Hazama K; Akutsu Y; Aoyagi H; Tobise C; Azuma K; Yasoshima K; Sawada Y; Uetsuji K; Tsuchida A; Tsuchiyama A; Yasuda K; Odagawa Y; Yoshioka M
J Infect Chemother; 2018 Jun; 24(6):449-457. PubMed ID: 29487035
[TBL] [Abstract][Full Text] [Related]
5. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
Sugaya N; Sakai-Tagawa Y; Bamba M; Yasuhara R; Yamazaki M; Kawakami C; Yamaguchi Y; Ide Y; Ichikawa M; Mitamura K; Kawaoka Y
Antivir Ther; 2015; 20(1):49-55. PubMed ID: 24832015
[TBL] [Abstract][Full Text] [Related]
6. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
[TBL] [Abstract][Full Text] [Related]
7. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013.
Meijer A; Rebelo-de-Andrade H; Correia V; Besselaar T; Drager-Dayal R; Fry A; Gregory V; Gubareva L; Kageyama T; Lackenby A; Lo J; Odagiri T; Pereyaslov D; Siqueira MM; Takashita E; Tashiro M; Wang D; Wong S; Zhang W; Daniels RS; Hurt AC
Antiviral Res; 2014 Oct; 110():31-41. PubMed ID: 25043638
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Clinical Courses of Patients with Influenza after Neuraminidase Inhibitors Treatment: A Postcard Survey of the 2013-2014 Influenza Season in Osaka.
Yoshi N; Tocino Y; Fujioka M; Kureya Y; Asai K; Kimura T; Shinataku H; Hirata K
Osaka City Med J; 2016 Dec; 62(2):29-38. PubMed ID: 30550708
[TBL] [Abstract][Full Text] [Related]
9. Optimizing antiviral therapy for influenza: understanding the evidence.
Ison MG
Expert Rev Anti Infect Ther; 2015 Apr; 13(4):417-25. PubMed ID: 25695406
[TBL] [Abstract][Full Text] [Related]
10. Trends of neuraminidase inhibitors use in children with influenza related respiratory infections.
Uda K; Okubo Y; Shoji K; Miyairi I; Morisaki N; Michihata N; Matsui H; Fushimi K; Yasunaga H
Pediatr Pulmonol; 2018 Jun; 53(6):802-808. PubMed ID: 29673121
[TBL] [Abstract][Full Text] [Related]
11. In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010-2011 season in Japan.
Ikematsu H; Kawai N; Kashiwagi S
J Infect Chemother; 2012 Aug; 18(4):529-33. PubMed ID: 22370919
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of laninamivir and peramivir in patients with seasonal influenza: a randomized clinical trial.
Yoshino Y; Seo K; Koga I; Kitazawa T; Ota Y
Infect Dis (Lond); 2017 May; 49(5):417-419. PubMed ID: 27766921
[No Abstract] [Full Text] [Related]
13. The effect of neuraminidase inhibitors on household transmission in Japanese patients with influenza A and B infection: A prospective, observational study.
Hirotsu N; Saisho Y; Hasegawa T
Influenza Other Respir Viruses; 2019 Mar; 13(2):123-132. PubMed ID: 29989680
[TBL] [Abstract][Full Text] [Related]
14. Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir.
Tamura D; DeBiasi RL; Okomo-Adhiambo M; Mishin VP; Campbell AP; Loechelt B; Wiedermann BL; Fry AM; Gubareva LV
J Infect Dis; 2015 Oct; 212(8):1209-13. PubMed ID: 25943200
[TBL] [Abstract][Full Text] [Related]
15. Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses.
Farrukee R; Mosse J; Hurt AC
Expert Rev Anti Infect Ther; 2013 Nov; 11(11):1135-45. PubMed ID: 24093683
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study.
Zhang Y; Gao H; Liang W; Tang L; Yang Y; Wu X; Yu L; Chen P; Zheng S; Ou H; Li L
BMC Infect Dis; 2016 Feb; 16():76. PubMed ID: 26864456
[TBL] [Abstract][Full Text] [Related]
17. Effects of corticosteroid and neuraminidase inhibitors on survival in patients with respiratory distress induced by influenza virus.
Huang SF; Fung CP; Perng DW; Wang FD
J Microbiol Immunol Infect; 2017 Oct; 50(5):586-594. PubMed ID: 26542650
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan.
Yoshino Y; Seo K; Koga I; Kitazawa T; Ota Y
Clin Respir J; 2015 Apr; 9(2):228-32. PubMed ID: 24612842
[TBL] [Abstract][Full Text] [Related]
19. A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults.
Ison MG; Hui DS; Clezy K; O'Neil BJ; Flynt A; Collis PJ; Simon TJ; Alexander WJ
Antivir Ther; 2013; 18(5):651-61. PubMed ID: 23111657
[TBL] [Abstract][Full Text] [Related]
20. A Meta-Analysis Comparing the Efficacy and Safety of Peramivir with Other Neuraminidase Inhibitors for Influenza Treatment.
Chen JY; Wei SK; Lai CC; Weng TS; Wang HH
Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32033501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
